IRIS UniCatt

Innocenti, Idanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.752
AS - Asia 3.294
EU - Europa 2.812
SA - Sud America 845
AF - Africa 91
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 10.803
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.659
SG - Singapore 1.558
CN - Cina 911
BR - Brasile 692
SE - Svezia 629
IT - Italia 534
DE - Germania 515
FR - Francia 238
VN - Vietnam 204
IE - Irlanda 179
IN - India 155
GB - Regno Unito 148
UA - Ucraina 134
ID - Indonesia 126
FI - Finlandia 119
RU - Federazione Russa 91
PL - Polonia 66
AR - Argentina 57
BD - Bangladesh 51
CA - Canada 46
HK - Hong Kong 44
JP - Giappone 37
TR - Turchia 37
KR - Corea 34
MX - Messico 34
AT - Austria 28
EC - Ecuador 28
CI - Costa d'Avorio 27
IQ - Iraq 27
BE - Belgio 22
ES - Italia 21
NL - Olanda 19
CO - Colombia 17
VE - Venezuela 16
ZA - Sudafrica 16
UZ - Uzbekistan 14
CZ - Repubblica Ceca 13
PY - Paraguay 13
IR - Iran 12
PK - Pakistan 12
IL - Israele 11
MA - Marocco 11
KE - Kenya 9
CH - Svizzera 8
EG - Egitto 8
BO - Bolivia 7
CL - Cile 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
TN - Tunisia 6
JO - Giordania 5
KZ - Kazakistan 5
LT - Lituania 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
DZ - Algeria 4
GR - Grecia 4
HU - Ungheria 4
LK - Sri Lanka 4
PE - Perù 4
PH - Filippine 4
QA - Qatar 4
RO - Romania 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
ET - Etiopia 3
HR - Croazia 3
LB - Libano 3
NP - Nepal 3
OM - Oman 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
BB - Barbados 2
CY - Cipro 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LU - Lussemburgo 2
NI - Nicaragua 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
Totale 10.790
Salva come PNG Salva come JPEG
Città #
Chandler 666
Singapore 656
Ashburn 329
Beijing 234
Dublin 174
Rome 125
Jakarta 115
Dearborn 112
Hefei 108
Los Angeles 106
San Mateo 103
Jacksonville 102
Wilmington 96
Ann Arbor 93
New York 87
Munich 79
Cattolica 76
Ho Chi Minh City 76
Nanjing 73
Boston 71
Hyderabad 69
Dallas 66
Chicago 64
Florence 62
Milan 61
Princeton 61
Warsaw 61
Marseille 60
Frankfurt am Main 58
Fairfield 55
Woodbridge 50
Moscow 49
Hanoi 46
Houston 46
Lancaster 46
São Paulo 44
Buffalo 43
Hong Kong 41
Nanchang 39
Seattle 39
Bremen 35
Helsinki 35
Seoul 33
Lawrence 30
Turku 30
Abidjan 27
Kent 26
Kunming 26
Rio de Janeiro 26
Redwood City 25
Tokyo 24
Brooklyn 23
Shenyang 23
Brussels 22
Boardman 21
Cambridge 21
Lappeenranta 20
Tianjin 20
Düsseldorf 17
Minneapolis 17
Nuremberg 17
Redmond 17
Santa Clara 17
Vienna 17
Albany 16
Izmir 16
London 16
Shanghai 16
The Dalles 16
Naples 15
Phoenix 15
Pune 15
Stockholm 15
Washington 15
Dhaka 14
Lauterbourg 14
Norwalk 14
Nürnberg 14
Tashkent 14
Zhengzhou 14
Auburn Hills 13
Mountain View 13
Salt Lake City 13
Tampa 13
Hebei 12
Mexico City 12
Porto Alegre 12
San Francisco 12
Toronto 12
Atlanta 11
Guayaquil 11
Jiaxing 11
Belo Horizonte 10
Guangzhou 10
Johannesburg 10
Montreal 10
Baghdad 9
Bogotá 9
Campinas 9
Changsha 9
Totale 5.570
Salva come PNG Salva come JPEG
Nome #
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 315
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 191
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR 182
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 165
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. 160
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 157
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 150
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 149
Role of microRNAs in Chronic Lymphocytic Leukemia 139
Chemoprevention of lung pathologies by dietary n-3 polyunsaturated fatty acids. 139
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. 138
The effects of omega-3 polyunsaturated fatty acids against cancer 135
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 134
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 133
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification 132
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 125
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 122
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 121
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 121
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 119
Mycosis fungoides as a cause of severe obstructive sleep apnea 118
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 117
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 114
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 111
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 106
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 105
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 105
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma 104
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. 103
Unrelated cord blood transplantation and post-transplant cyclophosphamide 103
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients 102
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 100
the concomitance of lymphoma and breast carcinoma in the bone 99
Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia 96
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 96
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 94
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments. 93
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 92
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study 92
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 91
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 91
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 91
Second haploidentical stem cell transplantation for primary graft failure 91
Chronic Lymphocitic Leukaemia: Census of Patients Treated in Italian Haematology Units 89
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 88
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 87
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. 87
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 87
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia 86
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 84
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 84
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 83
Unrelated cord blood transplantation and post-transplant cyclophosphamide 83
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 82
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 81
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 81
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 81
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 80
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 80
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199 79
Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role 79
CD49d promotes disease progression in chronic lymphocytic leukemia: New insights from CD49d bimodal expression 79
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 78
B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation 78
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 78
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 77
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 77
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 77
Richter transformation in Chronic Lymphocytic Leukemia 76
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 76
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 76
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 75
Validation of the CLL-IPI and comparison with the MDACC prognostic index: analysis of 1364 newly diagnosed patients 74
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 74
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 73
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 73
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 72
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 72
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia 71
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 71
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 71
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab 70
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 69
The concomitance of lymphoma and breast carcinoma in the bone 69
Second haploidentical stem cell transplantation for primary graft failure 68
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 67
Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience 67
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 67
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia 66
Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients 66
Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role 66
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 65
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment 65
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia 65
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort 64
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 64
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 63
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 63
Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases 63
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 63
Totale 9.590
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.989
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.989
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021211 0 0 0 0 0 33 25 11 42 17 75 8
2021/2022763 61 27 27 38 56 14 9 115 31 40 182 163
2022/20231.857 254 250 133 259 145 238 107 137 208 43 64 19
2023/20241.010 45 268 63 64 41 147 69 34 18 42 106 113
2024/20252.227 49 69 145 77 179 68 67 87 271 259 577 379
2025/20263.033 805 199 386 689 895 59 0 0 0 0 0 0
Totale 10.997